Investing

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

by admin

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

Related Posts

Editor’s Picks: Gold, Silver Prices Dip and Bounce...

Top 5 Canadian Mining Stocks This Week: Trinity...

Keith Weiner: Silver Being Remonetized “With a Vengeance”...

When Diamonds Are Not Forever: NWT’s Diamond Industry...

Crypto Market Update: Coinbase Posts US$667 Million Q4...

Tech Weekly: AI “Scare Trade” Spills into New...